博鱼·体育(中国)入口|主页

Press Releases
Home News

Press Releases

Hansoh Pharma's Clinical Trial Application for Innovative Drug HS-20094 Accepted
Release Date:2021/06/04
Font Size

Recently, the clinical trial application of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company") for HS-20094, an independently developed innovative drug, was accepted by the National Medical Products Administration (NMPA). 


▲ Screenshot of public information from CDE, NMPA

 

HS-20094 is a new-generation GIP/GLP-1 dual agonist independently developed by Hansoh Pharma, intended for the treatment of diabetes.

Baidu
sogou